Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of exercise and high-dose salbutamol on maximal heart rate after indacaterol and salmeterol in COPD
2007-001051-19Phase 2Completed
- Sponsor
- Novartis
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of indacaterol in chronic obstructive pulmonary disease (COPD), sponsored by Novartis. Started Jun 2007; status: completed.
02
Drugs
indacaterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2007-001051-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001051-19.